Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
76 Leser
Artikel bewerten:
(0)

Global POC Blood Gas and Electrolyte Market Growth at CAGR of 5.95%, 2017-2021

DUBLIN, September 13, 2017 /PRNewswire/ --

The "Global POC Blood Gas and Electrolyte Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global POC blood gas and electrolyte market to grow at a CAGR of 5.95% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global POC blood gas and electrolyte market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various types of analyzers and consumables used for treatment.

The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the major drivers for this market is Rising geriatric population. The rise in older population globally will increase the adoption of POC devices, which impacts the growth of the POC blood gas and electrolyte market positively. The rapid increase in older population worldwide has far-reaching implications on the public health system of the various counties in the Americas, EMEA, and APAC. Also, it will create demand for POC blood gas and electrolyte products mostly in home care settings.

The latest trend gaining momentum in the market is Paradigm shift from benchtop to portable POC blood gas and electrolyte devices. The blood gas and electrolyte testing market is undergoing a radical change with the introduction of compact devices. The growing diversity of tests that can be undertaken near the bedside of patients denotes the prevalence of multi-parameter checking POC devices. The accuracy of portable blood gas and electrolyte devices, has motivated hospitals and clinics to switchover to the POC variant from the benchtop variant. Other factors such as cost-effectiveness and rapid turnaround times are also encouraging adoption. The global POC blood gas and electrolyte is additionally seeing high adoption of combined analyzers.

Further, the report states that one of the major factors hindering the growth of this market is High cost of replacement and maintenance. The need for replacement of terminals, pump tubes, principle tubing, and valves used in POC blood gas and electrolyte products adds to the cost in clinics and laboratories and also negatively affects round-the-clock operations. If any of the components stop functioning, it renders the product ineffective. Maintenance and sanitation are also important factors to consider keeping the products functional for a long time, which also adds to the costs. Therefore, many of the end-users are opting for low-cost refurbished analyzers, where the cost of replacing components is comparatively low. The shift from new POC blood gas and electrolyte analyzers to a refurbished one minimizes the product's lifecycle and often produces inaccurate result as well. This could affect the sales of original equipment manufacturers and thereby the market growth.

Key vendors

  • Alere
  • F. Hoffmann-La Roche
  • Instrumentation Laboratory
  • Radiometer

Other prominent vendors

  • Abbott
  • Bayer
  • Cornley
  • Convergent Technologies
  • Edan Instruments
  • Erba Diagnostics
  • Fortress Diagnostics
  • i.SENS
  • JOKOH
  • LifeHealth
  • Medica
  • Nova Biomedical
  • OPTI Medical (Idexx)
  • Perlong Medical
  • SENSACORE
  • Siemens Healthineers
  • Sphere Medical
  • ZOLL Medical

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by products

  • Market overview
  • Consumables
  • Instruments

PART 07: Market segmentation by end-user

  • Market overview
  • Hospitals and clinics
  • Clinical diagnostic laboratories
  • Homecare settings

PART 08: Geographical segmentation

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Paradigm shift from benchtop to portable POC blood gas and electrolyte devices
  • Data management and connectivity through interoperability
  • Shift from traditional central laboratory blood gas analysis to near-patient site testing

PART 12: Vendor landscape

  • Competitive landscape

PART 13: Key vendor analysis

For more information about this report visit https://www.researchandmarkets.com/research/xqnjqf/global_poc_blood

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

© 2017 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.